Mapping large numbers of results may take a few moments.
Search Results
Showing 1 - 50 of 500 results found.
| Company | Activity | Company Description | Location | |
|---|---|---|---|---|
|
Company Sio Gene Therapies | Activity: Research and Development | Company Description Sio Gene Therapies develops gene therapies to treat neurologic conditions. | Location Durham |
|
Company StrideBio Inc. | Activity: Research and Development | Company Description StrideBio develops engineered viral vectors for gene therapy for the treatment of rare diseases. StrideBio's technology engine utilizes structure-inspired design to engineer AAV vectors which can escape pre-existing neutralizing antibodies (NAbs). | Location Research Triangle Park |
 |
Company 21MedTech | Activity: Research and Development | Company Description 21MedTech develops and offers advanced, proprietary, bioresorbable resins for controlled release drug delivery, regenerative devices and 3D manufacturing. | Location Durham |
| |
Company 3i-Nano | Activity: Research and Development | Company Description 3i Nano develops point-of-care devices for disease diagnostics and protein detection. | Location Greensboro |
| |
Company 410 Medical Inc. | Activity: Research and Development | Company Description 410 Medical is developing technology for rapid infusion of fluids and blood products for hospital, transport and military healthcare providers, enabling clinicians to quickly and effectively resuscitate critically ill patients. | Location Durham |
| |
Company 5Metis Inc. | Activity: Research and Development | Company Description 5Metis creates new active ingredients, products, and manufacturing processes for the crop protection industry. | Location Durham |
| |
Company 908 Devices Inc. | Activity: Production and Manufacturing | Company Description 908 Devices develops and makes chemical analysis products such as handheld chemical detection tools, compact analyzers and separation devices. | Location Carrboro |
| |
Company AavantiBio (RTP) | Activity: Research and Development | Company Description AavantiBio is developing novel gene transfer and gene editing therapies for the treatment of rare and ultra-rare genetic diseases. | Location Research Triangle Park |
| |
Company AccuNovo Biotechnologies Inc. | Activity: Research and Development | Company Description Accunovo develops targeted PET imaging probes for early cancer diagnosis. | Location Chapel Hill |
| |
Company Aceragen Inc. | Activity: Research and Development | Company Description Aceragen is a drug development company advancing a late-stage therapy for Farber disease | Location Research Triangle Park |
| |
Company Achelios Therapeutics Inc. | Activity: Research and Development | Company Description Achelios Therapeutics develops novel topical therapies for inflammatory pain, such as joint, muscle temporomandibular and migraine pain. | Location Durham |
| |
Company Adámas Nanotechnologies Inc. | Activity: Production and Manufacturing | Company Description Adámas Nanotechnologies develops and produces fluorescent nanodiamond particles for life science, medical and industrial applications, including life science research, drug delivery, bioimaging, anti-counterfeiting, oil additives and cosmetics. | Location Raleigh |
| |
Company Advanced Animal Diagnostics Inc. | Activity: Research and Development | Company Description Advanced Animal Diagnostics (AAD) develops and commercializes diagnostics to detect and manage disease states, reproductive, nutritional and overall health status of production animals. | Location Morrisville |
| |
Company Advanced Chemotherapy Technologies Inc. | Activity: Research and Development | Company Description Advanced Chemotherapy Technologies, a UNC startup, has developed a novel device for infusing chemotherapies directly into poorly-vascularized pancreatic tumors. | Location Raleigh |
| |
Company Aegis Surgical Ltd. | Activity: Research and Development | Company Description AEGIS is developing a less invasive access system that facilitates percutaneous transaortic transcatheter aortic valve replacement (pTAo-TAVR). | Location Durham |
| |
Company AegisCN LLC | Activity: Research and Development | Company Description AegisCN develops technologies and treatments targeting neurological diseases and inflammation. | Location Durham |
| |
Company Aerami Therapeutics | Activity: Research and Development | Company Description Aerami Therapeutics develops soft mist inhaled formulations of biologics and inhalation devices to treat severe and chronic diseases. Its first product is for the treatment of diabetes. | Location Durham |
| |
Company Aerie Pharmaceuticals Inc. | Activity: Research and Development | Company Description Aerie Pharmaceuticals discovers, develops and commercializes first-in-class therapies for the treatment of patients with glaucoma, dry eye, retinal diseases and other diseases of the eye. | Location Durham |
| |
Company Aestas Pharma Inc. | Activity: Research and Development | Company Description Asetas Pharma develops novel diagnostic imaging and disease-modifying therapeutic agents to enable the early treatment and reversal of Alzheimer’s and Parkinson’s disease when clinical signs are not yet pronounced. | Location Durham |
| |
Company Affinergy LLC | Activity: Research and Development | Company Description Affinergy develops peptide-based technologies, including diagnostic products, research tools and therapeutic drug monitoring products for use by clinicians and researchers. | Location Morrisville |
| |
Company AgBiome Inc. | Activity: Research and Development | Company Description AgBiome uses its proprietary Genesis platform to collect, isolate and analyze microbes for use in the discovery and development of biologicals and traits for protecting crops and is researching probiotic products to address swine gut health challenges. | Location Research Triangle Park |
| |
Company Agile Sciences Inc. | Activity: Research and Development | Company Description Agile Sciences is developing small molecules that inhibit bacterial resistance through a novel mode of action that enhances antibiotic activity. | Location Raleigh |
| |
Company AgriCureTech LLC | Activity: Research and Development | Company Description AgriCureTech develops technology to improve natural disease resistance of crops. | Location Raleigh |
| |
Company AI Tracking Solutions LLC | Activity: Research and Development | Company Description AI Tracking Solutions develops a single-particle tracking software that tracks entities including nanoparticles, viruses, bacteria and cells within fluids and biological samples and generates individual traces and statistical analysis of the traces. | Location Carrboro |
| |
Company AimMax Therapeutics Inc. | Activity: Research and Development | Company Description AimMax Therapeutics researches and develops biopharmaceuticals for the treatment of infection, inflammation and pain through in-licensing or co-development with strategic partners. | Location Durham |
| |
Company Ajinomoto North America | Activity: Production and Manufacturing | Company Description Ajinomoto North America manufactures pharmaceutical-grade amino acids and custom-blended amino acid mixtures. | Location Raleigh |
| |
Company Alcami Corporation (Morrisville) | Activity: Production and Manufacturing | Company Description Alcami's facility in Morrisville is a CDMO offering parenteral manufacturing options for pharma and biotechnology clients. Alcami provides an isolator manufacturing environment for liquid and lyophilized vial and syringe manufacturing. | Location Morrisville |
| |
Company Algaen Corp. | Activity: Research and Development | Company Description Algaen uses microalgae to develop, produce and market products and technologies for the nutraceutical, pharmaceutical and bio-energy industries. | Location Winston-Salem |
| |
Company Alievio Inc. | Activity: Research and Development | Company Description Alievio is developing an ocular implant to treat late stage glaucoma. | Location Research Triangle Park |
| |
Company Almac Clinical Services LLC | Activity: Production and Manufacturing | Company Description Almac Clinical Services provides clinical trial material manufacturing, packaging and distribution services. | Location Durham |
| |
Company AlphaVax Inc. | Activity: Research and Development | Company Description AlphaVax develops vaccine technology with applications in infectious disease, cancer and biodefense threats. | Location Research Triangle Park |
| |
Company Altavant Sciences Inc. | Activity: Research and Development | Company Description Altavant is a clinical stage biopharmaceutical company developing therapies for rare respiratory diseases. Altavant's therapeutic focus is in pulmonary arterial hypertension (PAH) and bronchiolitis obliterans syndrome (BOS). | Location Cary |
| |
Company Alterna Therapeutics Inc. | Activity: Research and Development | Company Description Alterna Therapeutics is developing first-in-class small molecules targeting the SHIP enzyme. Alterna is exploring its lead compounds in the areas of obesity, diabetes, bone marrow transplant and post-myeloblative therapy, cancer and Alzheimer's disease. | Location Durham |
| |
Company Altis BioSystems Inc. | Activity: Research and Development | Company Description Altis Biosystems has developed a patent-pending stem cell platform that recreates the human intestinal epithelium, in a high-throughput format, for compound screening and microbiome research for biopharmaceutical companies. | Location Durham |
| |
Company Amalgent Therapeutics LLC | Activity: Research and Development | Company Description Amalgent is a clinical-stage company developing oral pain management therapeutics. | Location Chapel Hill |
| |
Company AMO Pharma Ltd. | Activity: Research and Development | Company Description AMO Pharma is developing new treatments for serious and debilitating diseases including rare genetic disorders. | Location Durham |
| |
Company Andersen Sterilizers Inc. | Activity: Production and Manufacturing | Company Description Andersen Products sells and services the Anprolene and EOGas lines of 100% ethylene oxide gas sterilizers. They also provide contract packaging and sterilization services for device manufacturers. | Location Haw River |
| |
Company AnelleO | Activity: Research and Development | Company Description AnelleO is developing a 3D-printed intravaginal ring that can be used for treating infertility and a wide range of other women's health conditions. | Location Chapel Hill |
| |
Company Aniluxx Biotechnology Inc. | Activity: Research and Development | Company Description Aniluxx Biotechnology translates human therapies to dogs, cats and horses to treat itching and pain. | Location Chapel Hill |
| |
Company Animal Cancer Dx | Activity: Research and Development | Company Description Animal Cancer Dx is a chemical and biomolecular diagnostic company developing technology for the early detection of cancer in dogs. | Location Raleigh |
| |
Company Antech Molecular Innovations LLC | Activity: Research and Development | Company Description Antech Molecular Innovations, a joint venture of Antech Diagnostics and Sentinel Biomedical, develops molecular solutions to detect disease in companion animals. | Location Raleigh |
| |
Company APIE Therapeutics Inc. | Activity: Research and Development | Company Description APIE Therapeutics is developing therapies for fibrosis and related diseases. Its biology platform is the activation of the Apelinergic System signaling pathway via Apelin/APJ receptors agonist drug therapies. | Location Cary |
| |
Company Appealing Products Inc. | Activity: Research and Development | Company Description Appealing Products develops products for forensics and personal protection from toxic materials such as inorganics, gases and poisons in foods, animal feeds and liquids. | Location Raleigh |
| |
Company Applied Catheter Technologies Inc. | Activity: Research and Development | Company Description Applied Catheter Technologies develops drug-coated medical devices that inhibit scar formation. The company's first products under development are catheters for male urethral stricture and devices that inhibit abdominal adhesions. | Location Winston-Salem |
| |
Company Arbiom Inc. | Activity: Research and Development | Company Description Arbiom develops technologies that convert residues from agriculture and forestry into a high-protein ingredient for aquaculture and animal feed. The Raleigh office is Arbiom's application center. | Location Durham |
| |
Company ARC Therapeutics LLC | Activity: Research and Development | Company Description ARC Therapeutics is developing novel cancer treatments through the selective inhibition of specific CDK (cyclin-dependent kinase) family members to address unmet medical needs of oncology patients. | Location Research Triangle Park |
| |
Company Arrivo BioVentures LLC | Activity: Research and Development | Company Description Arrivo BioVentures accelerates biologics and small molecules from IND readiness through a clinical proof of concept, with biologics in development for dermatologic conditions. | Location Morrisville |
| |
Company ARSPIChem LLC | Activity: Production and Manufacturing | Company Description Arspichem offers chemical product services to pharma, biotech industries, universities and research organizations to support drug discovery. Products and services include organic molecules, custom synthesis and pharmaceutical screening libraries. | Location Research Triangle Park |
| |
Company Artiam Bio Inc. | Activity: Research and Development | Company Description Artiam Bio is targeting the endocannabinoid system to treat diseases using pharmacology and medicinal chemistry approaches. Artiam Bio is initially focused on non-alcoholic and alcoholic liver diseases, Prader Willi syndrome and cannabis use disorder. | Location Morrisville |
| |
Company Artizan Biosciences Inc. | Activity: Research and Development | Company Description Artizan is developing a platform for identifying and targeting pathogenic intestinal bacteria, with a focus on inflammatory bowel disease and potential applications in autoimmune diseases, obesity, skin, lung and central nervous system diseases. | Location Durham |